Skip to main content
Published locations for First-line bevacizumab better than cetuximab/panitumumab in right-sided RAS WT mCRC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
First-line bevacizumab better than cetuximab/panitumumab in right-sided RAS WT mCRC
User login
Username
Password
Reset your password
/content/first-line-bevacizumab-better-cetuximab/panitumumab-right-sided-ras-wt-mcrc
/hematology-oncology/article/257187/gastrointestinal-cancer/first-line-bevacizumab-better-cetuximab